Search Results - "Packard, Kathleen A."

Refine Results
  1. 1

    Effect of a Financial Education and Coaching Program for Low-Income, Single Mother Households on Child Health Outcomes by Fuji, Kevin T, White, Nicole D, Packard, Kathleen A, Kalkowski, Julie C, Walters, Ryan W

    Published in Healthcare (Basel) (01-01-2024)
    “…The financial difficulties of parents have a negative impact on the health of their children. This problem is more pronounced in single mother families. There…”
    Get full text
    Journal Article
  2. 2

    Effects of histamine on Th1/Th2 cytokine balance by Packard, Kathleen A., Khan, Manzoor M.

    Published in International Immunopharmacology (01-07-2003)
    “…Atopic asthma is a chronic inflammatory disorder of the airways where upon exposure to allergens, the body mounts an immune response. This disease is…”
    Get full text
    Book Review Journal Article
  3. 3

    Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist by Leiter, Madeline R, Packard, Kathleen A, Qi, Yongyue, Krueger, Steven K

    Published in Heart international (01-01-2019)
    “…Rivaroxaban is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation…”
    Get full text
    Journal Article
  4. 4

    EVALUATION OF RIVAROXABAN ADMINISTRATION FOR ATRIAL FIBRILLATION IN A CARDIOLOGY PRACTICE by Packard, Kathleen A., Leiter, Madeline, Qi, Yongyue, Krueger, Steven

    “…Background Rivaroxaban (Xarelto) is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular…”
    Get full text
    Journal Article
  5. 5

    Knowledge, Perceptions, and Patterns of Fish Oil Use in Cardiac Patients by Hilleman, Daniel E., Teply, Robyn, Packard, Kathleen A.

    Published in Journal of pharmacy practice (01-10-2020)
    “…Background: Fish oils are the most widely used nonvitamin, nonmineral dietary supplements in the United States. They are not over-the-counter medications and…”
    Get full text
    Journal Article
  6. 6

    Treatment of Depression in Patients with Concomitant Cardiac Disease by Teply, Robyn M, Packard, Kathleen A, White, Nicole D, Hilleman, Daniel E, DiNicolantonio, James J

    Published in Progress in cardiovascular diseases (01-03-2016)
    “…Abstract Depressed patients are at increased risk of cardiovascular (CV) disease (CVD) and those with concomitant depression and CVD are at increased risk of…”
    Get full text
    Journal Article
  7. 7

    The pharmacist role in predicting and improving medication adherence in heart failure patients by Davis, Estella M, Packard, Kathleen A, Jackevicius, Cynthia A

    “…Heart failure is one of the most common reasons for hospital admissions in patients aged 65 years and older, with an estimated 1 million hospitalizations…”
    Get full text
    Journal Article
  8. 8

    Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery by Hilleman, Daniel E, Mohiuddin, Syed M, Packard, Kathleen A

    Published in Chest (01-02-2004)
    “…Patients who continue to smoke following coronary artery bypass graft surgery (CABG) have substantially poorer outcomes than patients able to stop smoking…”
    Get more information
    Journal Article
  9. 9

    Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin by Packard, Kathleen A, Hilleman, Daniel E

    Published in Cardiovascular therapeutics (01-12-2016)
    “…Suboptimal adherence to medications taken chronically for secondary prevention of cardiovascular disease (CVD, e.g., aspirin) continues to burden the…”
    Get more information
    Journal Article
  10. 10

    Pharmacologic Prophylaxis of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Beyond β-Blockers by Davis, Estella M., Packard, Kathleen A., Hilleman, Daniel E.

    Published in Pharmacotherapy (01-07-2010)
    “…Postoperative atrial fibrillation (POAF) is a frequent complication of cardiac surgery that increases patient morbidity, length of stay, and hospital costs. A…”
    Get full text
    Journal Article
  11. 11

    New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome by Davis, Estella M., Packard, Kathleen A., Knezevich, Jon T., Campbell, Jennifer A.

    Published in Pharmacotherapy (01-10-2011)
    “…Thrombosis is an underlying cause of many cardiovascular disorders, and generation of thrombi in the arterial circulation can lead to unstable angina,…”
    Get full text
    Journal Article
  12. 12

    Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery by Hilleman, Daniel E., Reyes, Antonio P., Mooss, Aryan N., Packard, Kathleen A.

    “…SUMMARY Purpose: Atrial fibrillation (AF) is the most common arrhythmic complication following coronary artery bypass graft surgery (CABG). The efficacy and…”
    Get full text
    Journal Article
  13. 13

    Impact of Ranolazine on Clinical Outcomes and Healthcare Resource Utilization in Patients with Refractory Angina Pectoris by Ling, Hua, Packard, Kathleen A., Burns, Tammy L., Hilleman, Daniel E.

    “…Background Ranolazine is a novel antianginal medication approved for the treatment of chronic angina. There are only limited data concerning the efficacy of…”
    Get full text
    Journal Article
  14. 14

    Emerging Antiplatelet Therapy for Coronary Artery Disease and Acute Coronary Syndrome by Packard, Kathleen A., Campbell, Jennifer A., Knezevich, Jon T., Davis, Estella M.

    Published in Pharmacotherapy (01-03-2012)
    “…Antiplatelet therapy is used widely with proven benefit for the prevention of further ischemic cardiac complications in patients with known coronary artery…”
    Get full text
    Journal Article
  15. 15

    Optimal aspirin dose in acute coronary syndromes: an emerging consensus by DiNicolantonio, James J, Norgard, Nicholas B, Meier, Pascal, Lavie, Carl J, O'Keefe, James H, Niazi, Asfandyar K, Chatterjee, Saurav, Packard, Kathleen A, D'Ascenzo, Fabrizio, Cerrato, Enrico, Biondi-Zoccai, Giuseppe, Bangalore, Sripal, Fuchs, Flavio D, Serebruany, Victor L

    Published in Future cardiology (01-03-2014)
    “…Numerous clinical trials testing the efficacy of aspirin for the secondary prevention of cardiovascular disease have been published. We reviewed the literature…”
    Get more information
    Journal Article
  16. 16

    Teaching Heart Failure Treatment Guidelines and Assessing Heart Failure Therapy by Packard, Kathleen A., Lenz, Thomas L., Destache, Christopher J.

    “…Objectives. To determine the effectiveness of the heart failure screening form in teaching heart failure treatment guidelines and prompting students to…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Development of a Composite Lifestyle Index and Its Relationship to Quality of Life Improvement: The CLI Pilot Study by Lenz, Thomas L., Gillespie, Nicole D., Skradski, Jessica J., Viereck, Laura K., Packard, Kathleen A., Monaghan, Michael S.

    Published in ISRN preventive medicine (2013)
    “…An important component to optimal health is quality of life (QOL). Several healthy lifestyle behaviors have independently shown to improve QOL. The…”
    Get full text
    Journal Article
  20. 20

    Randomized, Double-Blind, Crossover Comparison of Amlodipine and Valsartan in African-Americans with Hypertension Using 24-Hour Ambulatory Blood Pressure Monitoring by Maciejewski, Stephanie, Mohiuddin, Syed M., Packard, Kathleen A., Mooss, Aryan N., Reyes, Antonio P., Aryana, Arash, Hilleman, Daniel E.

    Published in Pharmacotherapy (01-07-2006)
    “…Study Objective. To compare the efficacy of amlodipine and valsartan in African‐American patients with hypertension using ambulatory blood pressure monitoring…”
    Get full text
    Journal Article